BRKR

MKT CAP:$6B

Bruker Corporation

Market Cap

$6B

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Healthcare·Medical - Devices·🇺🇸·NASDAQ

Stock Price

$36.22-$11.89 (-24.71%)

Apr 23, 2026

Company Details

Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States and internationally. The company operates through three segments: Bruker Scientific Instruments ...

CEO

Frank H. Laukien

IPO Date

Aug 4, 2000

Website

www.bruker.com

Key Metrics TTM

Revenue

$3.0B

+30.7% YoY

Net Income

$399M

EPS (Diluted)

$2.71

Free Cash Flow

$299M

Revenue / Share

$20.29

Gross Margin

50.5%

Operating Margin

13.9%

Net Margin

13.3%

FCF Margin

10.0%

P/S

1.9x

P/E

14.0x

Earnings Reports

Q3 2024

May 6, 2026

PENDING

Q2 2024

Aug 9, 2024

$801MEPS $0.05

FY 2023

Feb 29, 2024

$3.0BEPS $2.90

Q4 2023

Feb 29, 2024

$855M+20.6%EPS $1.41

Q4 2022

Dec 31, 2022

$708M+3.6%EPS $0.66

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 16	$375M	$167M	$34M
Q4 16	$470M	$220M	$77M
Q1 17	$385M	$176M	$38M
Q4 18	$554M	$273M	$106M
Q1 19	$461M	$215M	$42M
Q3 19	$521M	$254M	$88M
Q4 19	$600M	$298M	$120M
Q2 20	$425M	$183M	$40M
Q4 21	$684M	$344M	$132M
Q2 22	$588M	$300M	$74M
Q3 22	$639M	$335M	$135M
Q4 22	$708M	$366M	$131M
Q4 23	$855M	$430M	$104M
Q2 24	$801M	$385M	$48M

Valuation

Quarter	P/S	P/E
Q1 16	—	—
Q4 16	—	—
Q1 17	—	—
Q4 18	3.1x	29.1x
Q1 19	3.0x	28.0x
Q3 19	2.9x	29.2x
Q4 19	2.6x	23.4x
Q2 20	2.8x	30.3x
Q4 21	2.5x	24.3x
Q2 22	2.4x	25.7x
Q3 22	2.4x	23.6x
Q4 22	2.1x	18.0x
Q4 23	2.0x	12.7x
Q2 24	1.9x	14.0x

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 16	-$14M	-$22M
Q4 16	$91M	$80M
Q1 17	$33M	$21M
Q4 18	$132M	$112M
Q1 19	$14M	$4M
Q3 19	$52M	$36M
Q4 19	$136M	$108M
Q2 20	$12M	-$9M
Q4 21	$139M	$110M
Q2 22	-$44M	-$62M
Q3 22	$70M	$12M
Q4 22	$172M	$137M
Q4 23	$206M	$174M
Q2 24	$1M	-$24M

Capital Expenditures

Quarter	CapEx
Q1 16	$8M
Q4 16	$11M
Q1 17	$12M
Q4 18	$20M
Q1 19	$11M
Q3 19	$16M
Q4 19	$28M
Q2 20	$20M
Q4 21	$28M
Q2 22	$18M
Q3 22	$58M
Q4 22	$35M
Q4 23	$32M
Q2 24	$25M

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 19	+22.9%	+22.9%
Q3 19	+10.8%	+10.1%
Q4 19	+55.9%	+38.2%
Q2 20	-23.3%	-13.9%
Q4 21	+48.1%	+31.5%
Q2 22	+12.9%	+18.7%
Q3 22	+6.5%	+5.1%
Q4 22	+66.8%	+50.0%
Q4 23	+25.0%	+36.1%
Q2 24	+36.1%	+46.3%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 16	$2M	0.6%
Q4 16	$3M	0.6%
Q1 17	$3M	0.7%
Q4 18	$3M	0.6%
Q1 19	$3M	0.7%
Q3 19	$4M	0.8%
Q4 19	$0	0.0%
Q2 20	$3M	0.7%
Q4 21	$5M	0.8%
Q2 22	$0	0.0%
Q3 22	$5M	0.8%
Q4 22	$0	0.0%
Q4 23	$0	0.0%
Q2 24	$7M	0.9%

OpEx Breakdown

Quarter	R&D	G&A	SG&A
Q1 16	$36M	$93M	—
Q4 16	$38M	$100M	—
Q1 17	$38M	$98M	—
Q4 18	$45M	$117M	—
Q1 19	$46M	$120M	—
Q3 19	$46M	$126M	—
Q4 19	$47M	—	$130M
Q2 20	$44M	—	$99M
Q4 21	$58M	—	$153M
Q2 22	$60M	—	—
Q3 22	$56M	—	$145M
Q4 22	$64M	—	—
Q4 23	$84M	$212M	—
Q2 24	$92M	$221M	—

Revenue Segments

Quarter	Energy And Supercon Technologies	Scientific Instruments	Product	Product And Service Other	Service	Product and Service, Other
Q1 16	$27M	$350M	—	—	—	—
Q4 16	$39M	$435M	—	—	—	—
Q1 17	$40M	$346M	—	—	—	—
Q4 18	—	—	$471M	$2M	$81M	—
Q1 19	—	—	$383M	$1M	$77M	—
Q3 19	—	—	$441M	$2M	$79M	—
Q2 20	—	—	$347M	$2M	$76M	—
Q4 21	—	—	$576M	—	$105M	$2M
Q2 22	—	—	$486M	—	$101M	$2M
Q3 22	—	—	$537M	—	$101M	$1M
Q4 22	—	—	$597M	—	$110M	$2M
Q4 23	—	—	$716M	—	$378M	-$240M
Q2 24	—	—	$654M	—	—	$146M

Revenue by Geography

Quarter	Asia Pacific	D	Other Country	Rest Of Europe	U	Delaware	United States	China	Germany	Rest of Asia Pacific
Q1 19	$152M	$43M	$37M	$112M	$118M	—	—	—	—	—
Q3 19	$159M	$58M	$48M	$121M	$136M	—	—	—	—	—
Q4 19	$187M	$64M	$44M	$155M	$150M	—	—	—	—	—
Q2 20	$136M	$44M	$32M	$111M	$103M	—	—	—	—	—
Q4 21	$203M	—	$47M	$198M	—	$76M	$159M	—	—	—
Q2 22	—	—	$43M	$130M	—	—	$172M	$93M	$67M	$83M
Q3 22	—	—	$47M	$152M	—	—	$192M	$112M	$52M	$85M
Q2 24	—	—	$55M	$192M	—	—	$244M	$120M	$84M	$106M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$816M	$100M	$916M
Q2 22	$723M	$0	$723M
Q3 22	$626M	$0	$626M
Q4 22	$646M	$0	$646M
Q1 23	$598M	$0	$598M
Q2 23	$575M	$0	$575M
Q3 23	$364M	$0	$364M
Q4 23	$488M	$0	$488M
Q1 24	$340M	$0	$340M
Q2 24	$170M	$0	$170M
Q3 24	$148M	$0	$148M
Q4 24	$183M	$0	$183M
Q1 25	$184M	$0	$184M
Q2 25	$92M	$0	$92M
Q3 25	$293M	$0	$293M
Q4 25	$299M	$0	$299M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 16	164M	—	—
Q4 16	161M	-2.2%	—
Q1 17	161M	-0.1%	—
Q4 18	157M	-1.9%	—
Q1 19	158M	+0.3%	-3.9%
Q3 19	156M	-1.5%	-3.2%
Q4 19	155M	-0.1%	-3.2%
Q2 20	155M	-0.5%	-1.7%
Q4 21	153M	-1.4%	-3.4%
Q2 22	150M	-1.8%	-3.7%
Q3 22	149M	-0.8%	-4.4%
Q4 22	148M	-0.5%	-4.4%
Q4 23	146M	-1.3%	-4.3%
Q2 24	148M	+1.4%	-1.2%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 16	$62.6K	6K
Q4 16	$78.4K	6K
Q1 17	$64.2K	6K
Q4 18	$80.6K	7K
Q1 19	$67.2K	7K
Q3 19	$75.9K	7K
Q4 19	$83.0K	7K
Q2 20	$58.7K	7K
Q4 21	$88.0K	8K
Q2 22	$75.8K	8K
Q3 22	$82.3K	8K
Q4 22	$83.1K	9K
Q4 23	$88.0K	10K
Q2 24	$82.5K	10K

Revenue / Employee